IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

M Gyrd-Hansen, P Meier - Nature Reviews Cancer, 2010 - nature.com
The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many
types of human cancer and are associated with chemoresistance, disease progression and …

Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders

KRM Raja, L Kovarova, R Hajek - British journal of …, 2010 - Wiley Online Library
Flow cytometric immunophenotyping is considered an indispensable tool for the diagnosis,
classification and monitoring of disease in monoclonal gammopathies. The clinical …

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma

M Ladetto, G Pagliano, S Ferrero, F Cavallo… - Journal of Clinical …, 2010 - ascopubs.org
Purpose We investigated the effect on minimal residual disease, by qualitative and real-time
quantitative polymerase chain reaction (RQ-PCR), of a consolidation regimen that included …

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

J Hu, DR Handisides… - Blood, The Journal …, 2010 - ashpublications.org
Hypoxia is associated with increased metastatic potential and poor prognosis in solid
tumors. In this study, we demonstrated in the murine 5T33MM model that multiple myeloma …

INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support

J Li, M Favata, JA Kelley, E Caulder, B Thomas, X Wen… - Neoplasia, 2010 - Elsevier
Cytokines in the bone marrow of multiple myeloma patients activate Janus kinase
(JAK)/signal transducer and activator of transcription (STAT) signaling pathways in tumor …

The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells

Z Jagani, D Wiederschain, A Loo, D He, R Mosher… - Cancer research, 2010 - AACR
Bmi-1 is a member of the Polycomb group family of proteins that function in the epigenetic
silencing of genes governing self-renewal, differentiation, and proliferation. Bmi-1 was first …

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells

V Ramakrishnan, T Kimlinger, J Haug… - American journal of …, 2010 - Wiley Online Library
Interaction of myeloma cells with the bone marrow microenvironment is mediated in large
part through different cytokines, especially VEGF and IL6. These cytokines, especially IL6 …

Osteoblastogenesis and tumor growth in myeloma

S Yaccoby - Leukemia & lymphoma, 2010 - Taylor & Francis
Myeloma is associated with suppression of osteoblastogenesis, consequentially resulting in
increased osteoclast activity and induction of typical osteolytic bone disease. The molecular …

[HTML][HTML] Low Molecular–Weight Cyclin E Overexpression Shortens Mitosis, Leading to Chromosome Missegregation and Centrosome Amplification

R Bagheri-Yarmand, A Biernacka, K Hunt… - Cancer …, 2010 - ncbi.nlm.nih.gov
Overexpression of the low molecular–weight isoforms (LMW-E) of cyclin E induces
chromosome instability; however, the degree to which these tumor-specific forms cause …

Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells

GM Fuhler, M Baanstra, D Chesik… - Experimental cell …, 2010 - Elsevier
CD138 (Syndecan 1) is a heparan sulfate proteoglycan that concentrates heparan sulfate-
binding growth factors on the surface of normal and malignant plasma cells (multiple …